speb/financial-data huggingface dataset:
CCS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -19896000.00
CCS cash_flow (annual, 2022-12-31) — Change In Receivables: -10865000.00
CCS cash_flow (annual, 2022-12-31) — Change In Working Capital: -276379000.00
CCS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -10865000.00
CCS cash_flow (annual, 2022-12-31) — Changes In Cash: -13749000.00
CCS balance_sheet (annual, 2022-12-31) — Common Stock: 318000.00
CCS cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -26034000.00
CCS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2150215000.00
CCS cash_flow (annual, 2022-12-31) — Common Stock Payments: -133400000.00
CCS balance_sheet (annual, 2022-12-31) — Construction In Progress: 56615000.00
CCS income_statement (annual, 2022-12-31) — Cost Of Revenue: 3370269000.00
CCS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 169610000.00
CCS balance_sheet (annual, 2022-12-31) — Current Assets: 3521852000.00
CCS balance_sheet (annual, 2022-12-31) — Current Liabilities: 276536000.00
CCS cash_flow (annual, 2022-12-31) — Deferred Income Tax: 383000.00
CCS cash_flow (annual, 2022-12-31) — Deferred Tax: 383000.00
CCS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 11223000.00
CCS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 11223000.00
CCS balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 1526000.00
CCS income_statement (annual, 2022-12-31) — Diluted Average Shares: 32977935.00
CCS income_statement (annual, 2022-12-31) — Diluted EPS: 15.92
CCS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 525126000.00
CCS income_statement (annual, 2022-12-31) — EBIT: 704905000.00
CCS income_statement (annual, 2022-12-31) — EBITDA: 716128000.00
CCS balance_sheet (annual, 2022-12-31) — Employee Benefits: 80415000.00
CCS cash_flow (annual, 2022-12-31) — End Cash Position: 308492000.00
CCS balance_sheet (annual, 2022-12-31) — Financial Assets: 50312000.00
CCS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -274832000.00
CCS balance_sheet (annual, 2022-12-31) — Finished Goods: 2830645000.00
CCS cash_flow (annual, 2022-12-31) — Free Cash Flow: 264650000.00
CCS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 11564000.00
CCS balance_sheet (annual, 2022-12-31) — Goodwill: 30395000.00
CCS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 54559000.00
CCS balance_sheet (annual, 2022-12-31) — Gross PPE: 104311000.00
CCS income_statement (annual, 2022-12-31) — Gross Profit: 1135647000.00
CCS cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 168117000.00
CCS balance_sheet (annual, 2022-12-31) — Income Tax Payable: 0.00
CCS balance_sheet (annual, 2022-12-31) — Interest Payable: 10670000.00
CCS balance_sheet (annual, 2022-12-31) — Inventory: 2830645000.00
CCS balance_sheet (annual, 2022-12-31) — Invested Capital: 3367253000.00
CCS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -54264000.00
CCS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1511667000.00
CCS balance_sheet (annual, 2022-12-31) — Leases: 9015000.00
CCS balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
CCS balance_sheet (annual, 2022-12-31) — Loans Receivable: 25449000.00
CCS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 13947000.00
CCS balance_sheet (annual, 2022-12-31) — Long Term Debt: 1217038000.00
CCS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1217038000.00
CCS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 33667000.00
CCS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -149021000.00
CCS balance_sheet (annual, 2022-12-31) — Long Term Provisions: 30134000.00
CCS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 38681000.00
CCS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
CCS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -133400000.00
CCS balance_sheet (annual, 2022-12-31) — Net Debt: 920314000.00
CCS income_statement (annual, 2022-12-31) — Net Income: 525126000.00
CCS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 525126000.00
CCS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 525126000.00
CCS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 525126000.00
CCS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 525126000.00
CCS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 525126000.00
CCS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 525126000.00
CCS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
CCS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -115354000.00
CCS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -115354000.00
CCS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -44000.00
CCS cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -3805000.00
CCS balance_sheet (annual, 2022-12-31) — Net PPE: 88303000.00
CCS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -20168000.00
CCS cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
CCS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2095656000.00
CCS balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 20856000.00
CCS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 20856000.00
CCS income_statement (annual, 2022-12-31) — Normalized EBITDA: 726277000.00
CCS income_statement (annual, 2022-12-31) — Normalized Income: 532999398.99
CCS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 315347000.00
CCS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 13760000.00
CCS income_statement (annual, 2022-12-31) — Operating Income: 704905000.00
CCS income_statement (annual, 2022-12-31) — Operating Revenue: 4505916000.00
CCS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 31772791.00
CCS income_statement (annual, 2022-12-31) — Other Income Expense: -28005000.00
CCS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 24164000.00
CCS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 11036000.00
CCS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 288420000.00
CCS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 17903000.00
CCS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -17856000.00
CCS balance_sheet (annual, 2022-12-31) — Other Properties: 13467000.00
CCS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 25449000.00
CCS balance_sheet (annual, 2022-12-31) — Payables: 106926000.00
CCS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 276536000.00
CCS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CCS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 44342000.00
CCS income_statement (annual, 2022-12-31) — Pretax Income: 676900000.00
CCS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CCS cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
CCS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -20406000.00
CCS balance_sheet (annual, 2022-12-31) — Receivables: 78246000.00
CCS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3370269000.00
CCS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 11223000.00
CCS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1627021000.00
CCS cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -133400000.00
CCS balance_sheet (annual, 2022-12-31) — Restricted Cash: 68337000.00
CCS balance_sheet (annual, 2022-12-31) — Retained Earnings: 1565094000.00
CCS cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
CCS cash_flow (annual, 2022-12-31) — Sale Of PPE: 238000.00
CCS income_statement (annual, 2022-12-31) — Selling General And Administration: 430742000.00
CCS balance_sheet (annual, 2022-12-31) — Share Issued: 31772791.00
CCS cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 1478000000.00
CCS cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -1478000000.00
CCS income_statement (annual, 2022-12-31) — Special Income Charges: -10149000.00
CCS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 20049000.00
CCS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2150215000.00
CCS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2095656000.00
CCS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -2275601.01
CCS income_statement (annual, 2022-12-31) — Tax Provision: 151774000.00
CCS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
CCS balance_sheet (annual, 2022-12-31) — Total Assets: 3773767000.00
CCS balance_sheet (annual, 2022-12-31) — Total Capitalization: 3367253000.00
CCS balance_sheet (annual, 2022-12-31) — Total Debt: 1217038000.00
CCS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2150215000.00
CCS income_statement (annual, 2022-12-31) — Total Expenses: 3801011000.00
CCS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1623552000.00
CCS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 502450000.00
CCS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1347016000.00
CCS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
CCS income_statement (annual, 2022-12-31) — Total Unusual Items: -10149000.00
CCS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -10149000.00
CCS balance_sheet (annual, 2022-12-31) — Working Capital: 3245316000.00
CCS income_statement (annual, 2022-12-31) — Write Off: 10149000.00
CCS income_statement (annual, 2023-12-31) — +Operating Expense: 447311000.00
CCS income_statement (annual, 2023-12-31) — +Total Revenue: 3692185000.00
CCS balance_sheet (annual, 2023-12-31) — Accounts Payable: 147265000.00
CCS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 76213000.00
CCS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -25565000.00
CCS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 592989000.00
CCS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1877000.00
CCS balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 251852000.00
CCS income_statement (annual, 2023-12-31) — Basic Average Shares: 31918942.00
CCS income_statement (annual, 2023-12-31) — Basic EPS: 8.12
CCS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 308492000.00
CCS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 10436000.00
CCS cash_flow (annual, 2023-12-31) — Capital Expenditure: -131856000.00
CCS cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -88538000.00
CCS balance_sheet (annual, 2023-12-31) — Capital Stock: 318000.00
CCS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 226150000.00
CCS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 226150000.00
CCS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -29381000.00
CCS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 23863000.00
CCS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -131980000.00
CCS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 41628000.00
CCS cash_flow (annual, 2023-12-31) — Change In Account Payable: 40339000.00
CCS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -8037000.00
CCS cash_flow (annual, 2023-12-31) — Change In Inventory: -185095000.00
CCS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -45719000.00
CCS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -45276000.00
CCS cash_flow (annual, 2023-12-31) — Change In Payable: 40339000.00
CCS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 32302000.00
CCS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -15615000.00
CCS cash_flow (annual, 2023-12-31) — Change In Receivables: -23416000.00
CCS cash_flow (annual, 2023-12-31) — Change In Working Capital: -282819000.00
CCS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -23416000.00
CCS cash_flow (annual, 2023-12-31) — Changes In Cash: -66489000.00
CCS balance_sheet (annual, 2023-12-31) — Common Stock: 318000.00
CCS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -29381000.00
CCS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2386936000.00
CCS cash_flow (annual, 2023-12-31) — Common Stock Payments: -29899000.00
CCS balance_sheet (annual, 2023-12-31) — Construction In Progress: 136300000.00
CCS income_statement (annual, 2023-12-31) — Cost Of Revenue: 2891120000.00
CCS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 180143000.00
CCS balance_sheet (annual, 2023-12-31) — Current Assets: 3736348000.00
CCS balance_sheet (annual, 2023-12-31) — Current Liabilities: 327408000.00
CCS cash_flow (annual, 2023-12-31) — Deferred Income Tax: 3858000.00
CCS cash_flow (annual, 2023-12-31) — Deferred Tax: 3858000.00
CCS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 15774000.00
CCS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 15774000.00
CCS balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 5291000.00
CCS income_statement (annual, 2023-12-31) — Diluted Average Shares: 32209359.00
CCS income_statement (annual, 2023-12-31) — Diluted EPS: 8.05
CCS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 259224000.00
CCS income_statement (annual, 2023-12-31) — EBIT: 353754000.00
CCS income_statement (annual, 2023-12-31) — EBITDA: 369528000.00
CCS balance_sheet (annual, 2023-12-31) — Employee Benefits: 80133000.00
CCS cash_flow (annual, 2023-12-31) — End Cash Position: 242003000.00
CCS balance_sheet (annual, 2023-12-31) — Financial Assets: 51369000.00
CCS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 23863000.00
CCS balance_sheet (annual, 2023-12-31) — Finished Goods: 3016641000.00
CCS cash_flow (annual, 2023-12-31) — Free Cash Flow: -90228000.00
CCS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 3373000.00
CCS balance_sheet (annual, 2023-12-31) — Goodwill: 30395000.00
CCS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 61327000.00
CCS balance_sheet (annual, 2023-12-31) — Gross PPE: 230940000.00
CCS income_statement (annual, 2023-12-31) — Gross Profit: 801065000.00
CCS cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 80380000.00
CCS balance_sheet (annual, 2023-12-31) — Income Tax Payable: 0.00
CCS balance_sheet (annual, 2023-12-31) — Interest Payable: 10404000.00
CCS balance_sheet (annual, 2023-12-31) — Inventory: 3016641000.00
CCS balance_sheet (annual, 2023-12-31) — Invested Capital: 3688705000.00
CCS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -131980000.00
CCS balance_sheet (annual, 2023-12-31) — Investments And Advances: 27867000.00
CCS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 255689000.00
CCS balance_sheet (annual, 2023-12-31) — Land And Improvements: 1507000.00
CCS balance_sheet (annual, 2023-12-31) — Leases: 11373000.00
CCS balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
CCS balance_sheet (annual, 2023-12-31) — Loans Receivable: 27867000.00
CCS balance_sheet (annual, 2023-12-31) — Long Term Debt: 1301769000.00
CCS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1301769000.00
CCS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 105689000.00
CCS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -22546000.00
CCS balance_sheet (annual, 2023-12-31) — Long Term Provisions: 35183000.00
CCS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 71324000.00
CCS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CCS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -29899000.00
CCS balance_sheet (annual, 2023-12-31) — Net Debt: 1075619000.00
CCS income_statement (annual, 2023-12-31) — Net Income: 259224000.00
CCS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 259224000.00
CCS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 259224000.00
CCS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 259224000.00
CCS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 259224000.00
CCS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 259224000.00
CCS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 259224000.00
CCS cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 0.00
CCS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CCS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 83143000.00
CCS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 83143000.00
CCS cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -302000.00
CCS balance_sheet (annual, 2023-12-31) — Net PPE: 205375000.00
CCS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -43140000.00
CCS cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
CCS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2325609000.00
CCS balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 16998000.00
CCS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 16998000.00
CCS income_statement (annual, 2023-12-31) — Normalized EBITDA: 369528000.00
CCS income_statement (annual, 2023-12-31) — Normalized Income: 259224000.00
CCS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 41628000.00
CCS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 5295000.00
CCS income_statement (annual, 2023-12-31) — Operating Income: 353754000.00
CCS income_statement (annual, 2023-12-31) — Operating Revenue: 3692185000.00
CCS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 31774615.00
CCS income_statement (annual, 2023-12-31) — Other Income Expense: -2924000.00
CCS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 30932000.00
CCS balance_sheet (annual, 2023-12-31) — Other Investments: 27867000.00
CCS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1642000.00
CCS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 40078000.00
CCS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 7933000.00
CCS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -2924000.00
CCS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 27867000.00
CCS balance_sheet (annual, 2023-12-31) — Payables: 147265000.00
CCS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 327408000.00
CCS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CCS balance_sheet (annual, 2023-12-31) — Prepaid Assets: 47794000.00
CCS income_statement (annual, 2023-12-31) — Pretax Income: 350830000.00
CCS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CCS cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CCS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -43318000.00
CCS balance_sheet (annual, 2023-12-31) — Receivables: 76213000.00
CCS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2891120000.00
CCS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 15774000.00
CCS cash_flow (annual, 2023-12-31) — Repayment Of Debt: -172546000.00
CCS cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -29899000.00
CCS balance_sheet (annual, 2023-12-31) — Restricted Cash: 117698000.00
CCS balance_sheet (annual, 2023-12-31) — Retained Earnings: 1793629000.00
CCS cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CCS cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 0.00
CCS cash_flow (annual, 2023-12-31) — Sale Of PPE: 178000.00
CCS income_statement (annual, 2023-12-31) — Selling General And Administration: 447311000.00
CCS balance_sheet (annual, 2023-12-31) — Share Issued: 31774615.00
CCS cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 150000000.00
CCS cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -150000000.00
CCS income_statement (annual, 2023-12-31) — Special Income Charges: -1877000.00
CCS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 36777000.00
CCS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2386936000.00
CCS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2325609000.00
CCS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CCS income_statement (annual, 2023-12-31) — Tax Provision: 91606000.00
CCS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
CCS balance_sheet (annual, 2023-12-31) — Total Assets: 4139362000.00
CCS balance_sheet (annual, 2023-12-31) — Total Capitalization: 3688705000.00
CCS balance_sheet (annual, 2023-12-31) — Total Debt: 1301769000.00
CCS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2386936000.00
CCS income_statement (annual, 2023-12-31) — Total Expenses: 3338431000.00
CCS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1752426000.00
CCS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 403014000.00
CCS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1425018000.00
CCS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
CCS income_statement (annual, 2023-12-31) — Total Unusual Items: -1877000.00
CCS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1877000.00
CCS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CCS balance_sheet (annual, 2023-12-31) — Working Capital: 3408940000.00
CCS income_statement (annual, 2023-12-31) — Write Off: 1877000.00
CCS balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 1088000.00
CCS balance_sheet (quarterly, 2024-09-30) — Other Properties: 165117000.00
CCS cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: -49000.00
CCS cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 155000.00
CCS income_statement (quarterly, 2024-09-30) — Special Income Charges: -1373000.00
CCS income_statement (quarterly, 2024-09-30) — Total Unusual Items: -1373000.00
CCS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -1373000.00
CCS income_statement (quarterly, 2024-09-30) — Write Off: 1373000.00
CCS income_statement (annual, 2024-12-31) — +Operating Expense: 516489000.00
CCS income_statement (annual, 2024-12-31) — +Total Revenue: 4398288000.00
CCS balance_sheet (annual, 2024-12-31) — Accounts Payable: 133086000.00
CCS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 50318000.00
CCS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -32237000.00
CCS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -32237000.00
CCS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 526959000.00
CCS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 18680000.00
CCS balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 236926000.00
CCS income_statement (annual, 2024-12-31) — Basic Average Shares: 31510282.00
CCS income_statement (annual, 2024-12-31) — Basic EPS: 10.59
CCS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 242003000.00
CCS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 91952000.00
CCS balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 91952000.00
CCS cash_flow (annual, 2024-12-31) — Capital Expenditure: -165548000.00
CCS cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -126578000.00
CCS cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: -28549000.00
CCS balance_sheet (annual, 2024-12-31) — Capital Stock: 310000.00
CCS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 149998000.00
CCS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 149998000.00
CCS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -32751000.00
CCS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 40315000.00
CCS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -232690000.00
CCS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 125695000.00
CCS cash_flow (annual, 2024-12-31) — Change In Account Payable: -15571000.00
CCS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -4873000.00
CCS cash_flow (annual, 2024-12-31) — Change In Inventory: -313674000.00
CCS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 6087000.00
CCS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 98841000.00
CCS cash_flow (annual, 2024-12-31) — Change In Payable: -15571000.00
CCS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -20444000.00
CCS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -50951000.00
CCS cash_flow (annual, 2024-12-31) — Change In Receivables: 26501000.00
CCS cash_flow (annual, 2024-12-31) — Change In Working Capital: -253640000.00
CCS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 26501000.00
CCS cash_flow (annual, 2024-12-31) — Changes In Cash: -66680000.00
CCS balance_sheet (annual, 2024-12-31) — Common Stock: 310000.00
CCS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2620856000.00
CCS cash_flow (annual, 2024-12-31) — Common Stock Payments: -94311000.00
CCS balance_sheet (annual, 2024-12-31) — Construction In Progress: 119441000.00
CCS balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 119441000.00
CCS income_statement (annual, 2024-12-31) — Cost Of Revenue: 3444301000.00
CCS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 165779000.00
CCS balance_sheet (annual, 2024-12-31) — Current Assets: 3989711000.00
CCS balance_sheet (annual, 2024-12-31) — Current Debt: 135500000.00
CCS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 135500000.00
CCS balance_sheet (annual, 2024-12-31) — Current Liabilities: 434365000.00
CCS cash_flow (annual, 2024-12-31) — Deferred Income Tax: -5222000.00
CCS cash_flow (annual, 2024-12-31) — Deferred Tax: -5222000.00
CCS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 24286000.00
CCS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 24286000.00
CCS income_statement (annual, 2024-12-31) — Diluted Average Shares: 32110835.00
CCS income_statement (annual, 2024-12-31) — Diluted EPS: 10.40
CCS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 333816000.00
CCS income_statement (annual, 2024-12-31) — EBIT: 437498000.00
CCS income_statement (annual, 2024-12-31) — EBITDA: 461784000.00
CCS balance_sheet (annual, 2024-12-31) — Employee Benefits: 82020000.00
CCS cash_flow (annual, 2024-12-31) — End Cash Position: 175323000.00
CCS balance_sheet (annual, 2024-12-31) — Financial Assets: 92494000.00
CCS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 40315000.00
CCS balance_sheet (annual, 2024-12-31) — Finished Goods: 3454337000.00
CCS cash_flow (annual, 2024-12-31) — Free Cash Flow: -39853000.00
CCS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 6036000.00
CCS balance_sheet (annual, 2024-12-31) — Goodwill: 41109000.00
CCS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 83513000.00
CCS balance_sheet (annual, 2024-12-31) — Gross PPE: 306854000.00
CCS income_statement (annual, 2024-12-31) — Gross Profit: 953987000.00
CCS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 102384000.00
CCS balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
CCS balance_sheet (annual, 2024-12-31) — Interest Payable: 12457000.00
CCS balance_sheet (annual, 2024-12-31) — Inventory: 3454337000.00
CCS balance_sheet (annual, 2024-12-31) — Invested Capital: 4097069000.00
CCS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -232690000.00
CCS balance_sheet (annual, 2024-12-31) — Investments And Advances: 31858000.00
CCS balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 31858000.00
CCS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 2017082000.00
CCS balance_sheet (annual, 2024-12-31) — Land And Improvements: 9209000.00
CCS balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 9209000.00
CCS balance_sheet (annual, 2024-12-31) — Leases: 15306000.00
CCS balance_sheet (quarterly, 2024-12-31) — Leases: 15306000.00
CCS balance_sheet (annual, 2024-12-31) — Line Of Credit: 135500000.00
CCS balance_sheet (annual, 2024-12-31) — Loans Receivable: 31858000.00
CCS balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 31858000.00
CCS balance_sheet (annual, 2024-12-31) — Long Term Debt: 1340713000.00
CCS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1340713000.00
CCS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 116082000.00
CCS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -78727000.00
CCS balance_sheet (annual, 2024-12-31) — Long Term Provisions: 45732000.00
CCS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 70946000.00
CCS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 70946000.00
CCS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -159706000.00
CCS cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -2576000.00
CCS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -94311000.00
CCS balance_sheet (annual, 2024-12-31) — Net Debt: 1326215000.00
CCS income_statement (annual, 2024-12-31) — Net Income: 333816000.00
CCS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 333816000.00
CCS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 333816000.00
CCS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 333816000.00
CCS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 333816000.00
CCS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 333816000.00
CCS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 333816000.00
CCS cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: 91250000.00
CCS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 91250000.00
CCS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 172855000.00
CCS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 37355000.00
CCS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -5478000.00
CCS cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -5115000.00
CCS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -10474000.00
CCS balance_sheet (annual, 2024-12-31) — Net PPE: 274617000.00
CCS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -27182000.00
CCS cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 135500000.00
CCS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2537343000.00
CCS balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 22220000.00
CCS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 22220000.00
CCS income_statement (annual, 2024-12-31) — Normalized EBITDA: 461784000.00
CCS income_statement (annual, 2024-12-31) — Normalized Income: 333816000.00
CCS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 125695000.00
CCS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -18509000.00
CCS income_statement (annual, 2024-12-31) — Operating Income: 437498000.00
CCS income_statement (annual, 2024-12-31) — Operating Revenue: 4398288000.00
CCS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 30961227.00
CCS income_statement (annual, 2024-12-31) — Other Income Expense: 2562000.00
CCS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 42404000.00
CCS balance_sheet (annual, 2024-12-31) — Other Investments: 31858000.00
CCS balance_sheet (quarterly, 2024-12-31) — Other Investments: 31858000.00
CCS cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1584000.00
CCS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 69917000.00
CCS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 8786000.00
CCS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 2562000.00
CCS balance_sheet (annual, 2024-12-31) — Payables: 133086000.00
CCS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 298865000.00
CCS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CCS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 37945000.00
CCS income_statement (annual, 2024-12-31) — Pretax Income: 440060000.00
CCS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CCS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CCS cash_flow (annual, 2024-12-31) — Purchase Of Business: -159706000.00
CCS cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -2576000.00
CCS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -38970000.00
CCS balance_sheet (annual, 2024-12-31) — Receivables: 82176000.00
CCS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3444301000.00
CCS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 24286000.00
CCS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1844227000.00
CCS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -94311000.00
CCS balance_sheet (annual, 2024-12-31) — Restricted Cash: 28329000.00
CCS balance_sheet (annual, 2024-12-31) — Retained Earnings: 2093587000.00
CCS cash_flow (annual, 2024-12-31) — Sale Of Investment: 91250000.00
CCS cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 91250000.00
CCS cash_flow (annual, 2024-12-31) — Sale Of PPE: 11788000.00
CCS cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 619000.00
CCS income_statement (annual, 2024-12-31) — Selling General And Administration: 516489000.00
CCS balance_sheet (annual, 2024-12-31) — Share Issued: 30961227.00
CCS cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 1901000000.00
CCS cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -1765500000.00
CCS income_statement (annual, 2024-12-31) — Special Income Charges: -8778000.00
CCS income_statement (quarterly, 2024-12-31) — Special Income Charges: -6836000.00
CCS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 27868000.00
CCS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2620856000.00
CCS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2537343000.00
CCS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CCS income_statement (annual, 2024-12-31) — Tax Provision: 106244000.00
CCS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
CCS balance_sheet (annual, 2024-12-31) — Total Assets: 4532472000.00
CCS balance_sheet (annual, 2024-12-31) — Total Capitalization: 3961569000.00
CCS balance_sheet (annual, 2024-12-31) — Total Debt: 1476213000.00
CCS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2620856000.00
CCS income_statement (annual, 2024-12-31) — Total Expenses: 3960790000.00
CCS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1911616000.00
CCS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 542761000.00
CCS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1477251000.00
CCS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
CCS income_statement (annual, 2024-12-31) — Total Unusual Items: -8778000.00
CCS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -6836000.00
CCS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -8778000.00
CCS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -6836000.00
CCS balance_sheet (annual, 2024-12-31) — Working Capital: 3555346000.00
CCS income_statement (annual, 2024-12-31) — Write Off: 8778000.00
CCS income_statement (quarterly, 2024-12-31) — Write Off: 6836000.00
CCS income_statement (quarterly, 2025-03-31) — +Operating Expense: 120760000.00
CCS income_statement (quarterly, 2025-03-31) — +Total Revenue: 903232000.00
CCS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 134256000.00
CCS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 43800000.00
CCS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 454265000.00
CCS cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 411000.00
CCS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 207385000.00
CCS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 30801046.00
CCS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.28
CCS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 175323000.00
CCS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3380000.00
CCS cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: 0.00
CCS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 305000.00
CCS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 100336000.00
CCS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 100336000.00
CCS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -8922000.00
CCS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1479000.00
CCS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -4093000.00
CCS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -36580000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1170000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -17534000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Inventory: -50700000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 32728000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -21183000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Payable: 1170000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -16364000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -31290000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 6518000.00
CCS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -80291000.00
CCS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 6518000.00
CCS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -42152000.00
CCS balance_sheet (quarterly, 2025-03-31) — Common Stock: 305000.00
CCS cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -8922000.00
CCS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2578503000.00
CCS cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -55578000.00
CCS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
CCS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 724916000.00
CCS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 187632000.00
CCS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4176950000.00
CCS balance_sheet (quarterly, 2025-03-31) — Current Debt: 237000000.00
CCS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 237000000.00
CCS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 565664000.00
CCS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 295000.00
CCS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 295000.00
CCS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6428000.00
CCS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6428000.00
CCS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 31145867.00
CCS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.26
CCS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 39384000.00
CCS income_statement (quarterly, 2025-03-31) — EBIT: 57556000.00
CCS income_statement (quarterly, 2025-03-31) — EBITDA: 63984000.00
CCS balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 34365000.00
CCS cash_flow (quarterly, 2025-03-31) — End Cash Position: 133171000.00
CCS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 110968000.00
CCS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1479000.00
CCS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 3704394000.00
CCS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -39960000.00
CCS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 1506000.00
CCS balance_sheet (quarterly, 2025-03-31) — Goodwill: 41109000.00
CCS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 84998000.00
CCS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 86618000.00
CCS income_statement (quarterly, 2025-03-31) — Gross Profit: 178316000.00
CCS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CCS balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 6776000.00
CCS balance_sheet (quarterly, 2025-03-31) — Interest Payable: 16151000.00
CCS balance_sheet (quarterly, 2025-03-31) — Inventory: 3704394000.00
CCS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4135936000.00
CCS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4093000.00
CCS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 730642000.00
CCS balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 237000000.00
CCS balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 32843000.00
CCS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1320433000.00
CCS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1320433000.00
CCS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 730642000.00
CCS cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -649819000.00
CCS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 46918000.00
CCS cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CCS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -55578000.00
CCS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1457097000.00
CCS income_statement (quarterly, 2025-03-31) — Net Income: 39384000.00
CCS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 39384000.00
CCS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 39384000.00
CCS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 39384000.00
CCS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 39384000.00
CCS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 39384000.00
CCS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 39384000.00
CCS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 80823000.00
CCS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 80823000.00
CCS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -572000.00
CCS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -713000.00
CCS balance_sheet (quarterly, 2025-03-31) — Net PPE: 86618000.00
CCS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3380000.00
CCS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2493505000.00
CCS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 21925000.00
CCS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 21925000.00
CCS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 63984000.00
CCS income_statement (quarterly, 2025-03-31) — Normalized Income: 39384000.00
CCS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -36580000.00
CCS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1555000.00
CCS income_statement (quarterly, 2025-03-31) — Operating Income: 57556000.00
CCS income_statement (quarterly, 2025-03-31) — Operating Revenue: 903232000.00
CCS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 30546570.00
CCS income_statement (quarterly, 2025-03-31) — Other Income Expense: -5038000.00
CCS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 43889000.00
CCS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -4654000.00
CCS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 74819000.00
CCS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 10395000.00
CCS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -5038000.00
CCS balance_sheet (quarterly, 2025-03-31) — Other Properties: 86618000.00
CCS balance_sheet (quarterly, 2025-03-31) — Payables: 141032000.00
CCS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 328664000.00
CCS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CCS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 31170000.00
CCS income_statement (quarterly, 2025-03-31) — Pretax Income: 52518000.00
CCS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -17230000.00
CCS cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CCS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3380000.00
CCS balance_sheet (quarterly, 2025-03-31) — Receivables: 76643000.00
CCS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 724916000.00
CCS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6428000.00
CCS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -649819000.00
CCS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -55578000.00
CCS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 57022000.00
CCS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2123933000.00
CCS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 120760000.00
CCS balance_sheet (quarterly, 2025-03-31) — Share Issued: 30546570.00
CCS income_statement (quarterly, 2025-03-31) — Special Income Charges: -411000.00
CCS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 292000.00
CCS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2578503000.00
CCS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2493505000.00
CCS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CCS income_statement (quarterly, 2025-03-31) — Tax Provision: 13134000.00
CCS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
CCS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4556278000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3898936000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1557433000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2578503000.00
CCS income_statement (quarterly, 2025-03-31) — Total Expenses: 845676000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1977775000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 379328000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1412111000.00
CCS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 6776000.00
CCS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -411000.00
CCS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -411000.00
CCS balance_sheet (quarterly, 2025-03-31) — Working Capital: 3611286000.00
CCS income_statement (quarterly, 2025-03-31) — Write Off: 411000.00
CCS income_statement (quarterly, 2025-06-30) — +Operating Expense: 128837000.00
CCS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1000724000.00
CCS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 145269000.00
CCS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 68893000.00
CCS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 414002000.00
CCS cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 7360000.00
CCS balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 184390000.00
CCS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 30366109.00
CCS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.15
CCS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 133171000.00
CCS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6401000.00
CCS cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: 0.00